Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Oct 05, 2023 £263.50 £263.50 £263.50 £263.50 0
Oct 04, 2023 £268.50 £268.50 £264.06 £266.25 6 044
Oct 03, 2023 £273.50 £278.60 £268.00 £269.50 11 891
Oct 02, 2023 £278.25 £278.25 £278.25 £278.25 0
Sep 29, 2023 £271.00 £284.55 £271.00 £278.25 15 621
Sep 28, 2023 £273.00 £281.50 £272.00 £277.50 79 843
Sep 27, 2023 £280.00 £282.00 £276.50 £279.50 35 539
Sep 26, 2023 £273.00 £273.00 £258.50 £272.00 67 804
Sep 25, 2023 £254.00 £272.00 £254.00 £266.75 77 001
Sep 22, 2023 £255.50 £262.00 £249.00 £260.00 124 942
Sep 21, 2023 £251.00 £261.50 £247.00 £253.00 88 646
Sep 20, 2023 £255.00 £261.49 £248.00 £259.50 7 764
Sep 19, 2023 £264.50 £264.50 £250.49 £258.50 31 938
Sep 18, 2023 £259.00 £267.81 £251.50 £259.00 183 061
Sep 15, 2023 £242.00 £253.00 £238.00 £253.00 114 573
Sep 14, 2023 £239.00 £241.50 £230.00 £236.50 61 933
Sep 13, 2023 £239.50 £239.50 £232.30 £233.50 10 334
Sep 12, 2023 £243.50 £246.62 £232.50 £233.50 45 580
Sep 11, 2023 £232.50 £245.00 £232.50 £240.50 112 124
Sep 08, 2023 £216.12 £227.00 £216.12 £227.00 67 469
Sep 07, 2023 £232.50 £232.50 £232.50 £232.50 0
Sep 06, 2023 £236.50 £240.23 £228.00 £232.50 12 309
Sep 05, 2023 £242.50 £246.50 £234.50 £237.25 40 815
Sep 04, 2023 £240.00 £245.50 £234.50 £235.00 58 051
Sep 01, 2023 £243.85 £246.00 £237.00 £243.00 7 273
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT